Lyell Immunopharma, Inc. (LYEL)
15.43
+4.66
(+43.27%)
USD |
NASDAQ |
Nov 04, 16:00
15.04
-0.39
(-2.53%)
After-Hours: 07:32
Lyell Immunopharma Market Cap : 361.02M for Nov. 4, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2026 | 361.02M |
| November 03, 2026 | 251.99M |
| November 02, 2026 | 254.56M |
| October 30, 2026 | 258.30M |
| October 29, 2026 | 264.50M |
| October 28, 2026 | 255.73M |
| October 27, 2026 | 236.78M |
| October 26, 2026 | 217.83M |
| October 23, 2026 | 219.70M |
| October 22, 2026 | 219.46M |
| October 21, 2026 | 220.17M |
| October 20, 2026 | 226.95M |
| October 19, 2026 | 205.89M |
| October 16, 2026 | 189.98M |
| October 15, 2026 | 191.62M |
| October 14, 2026 | 186.94M |
| October 13, 2026 | 175.71M |
| October 12, 2026 | 193.49M |
| October 09, 2026 | 203.79M |
| October 08, 2026 | 205.66M |
| October 07, 2026 | 200.28M |
| October 06, 2026 | 201.45M |
| October 05, 2026 | 212.21M |
| October 02, 2026 | 216.66M |
| October 01, 2026 | 220.17M |
| Date | Value |
|---|---|
| September 30, 2026 | 229.06M |
| September 29, 2026 | 225.31M |
| September 28, 2026 | 227.89M |
| September 25, 2026 | 230.46M |
| September 24, 2026 | 236.78M |
| September 23, 2026 | 246.37M |
| September 22, 2026 | 260.88M |
| September 21, 2026 | 255.73M |
| September 18, 2026 | 257.60M |
| September 17, 2026 | 252.69M |
| September 16, 2026 | 252.10M |
| September 15, 2026 | 255.26M |
| September 14, 2026 | 265.09M |
| September 11, 2026 | 279.83M |
| September 10, 2026 | 285.44M |
| September 09, 2026 | 301.35M |
| September 08, 2026 | 316.56M |
| September 04, 2026 | 336.21M |
| September 03, 2026 | 335.04M |
| September 02, 2026 | 349.90M |
| September 01, 2026 | 339.84M |
| August 31, 2026 | 335.04M |
| August 28, 2026 | 339.96M |
| August 27, 2026 | 341.83M |
| August 26, 2026 | 346.28M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.701B |
| Oncolytics Biotech, Inc. | 52.95M |
| Sangamo Therapeutics, Inc. | 47.64M |
| Sarepta Therapeutics, Inc. | 2.006B |
| Anixa Biosciences, Inc. | 113.44M |
Market Cap Related Metrics
| PS Ratio | 12109.61 |
| Price to Book Value | 1.544 |
| Price | 15.43 |
| Earnings Yield | -76.27% |